Traws Pharma, Inc.TRAWNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P50
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q2 2025 | -2.82% |
| Q4 2024 | 3.69% |
| Q2 2024 | -29.58% |
| Q4 2023 | 10.22% |
| Q2 2023 | 4.90% |
| Q4 2022 | -4.69% |
| Q2 2022 | -0.76% |
| Q4 2021 | -13.99% |
| Q2 2021 | 29.10% |
| Q4 2020 | -10.82% |
| Q2 2020 | 31.45% |
| Q4 2019 | -32.85% |
| Q2 2019 | 36.87% |
| Q4 2018 | -7.61% |
| Q2 2018 | 12.34% |
| Q4 2017 | -9.88% |
| Q2 2017 | 0.49% |
| Q4 2016 | -25.90% |
| Q2 2016 | 30.78% |
| Q4 2015 | -27.71% |
| Q2 2015 | -10.79% |
| Q4 2014 | -30.45% |
| Q2 2014 | -13.68% |
| Q4 2013 | 59.83% |
| Q2 2013 | -44.38% |
| Q4 2012 | 184.32% |
| Q2 2012 | 0.00% |